BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25502291)

  • 1. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
    Li X; Zheng J; Chen L; Diao H; Liu Y
    Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
    Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H
    Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
    Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.
    Feng FQ; Liu GS; Li JC; Chen LZ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2870-2879. PubMed ID: 31002138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-183 expression and its clinical significance in human brain glioma.
    Ye Z; Zhang Z; Wu L; Liu C; Chen Q; Liu J; Wang X; Zhuang Z; Li W; Xu S; Hang C
    Neurol Sci; 2016 Aug; 37(8):1341-7. PubMed ID: 27215622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between downexpression of miR-1301 and poor prognosis in patients with glioma.
    Bai QL; Hu CW; Wang XR; Yin GF; Shang JX
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4298-4303. PubMed ID: 29077167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
    Ji Y; Wei Y; Wang J; Gong K; Zhang Y; Zuo H
    Tumour Biol; 2015 Aug; 36(8):6249-54. PubMed ID: 25773393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
    Cheng MW; Wang LL; Hu GY
    Asian Pac J Cancer Prev; 2015; 16(5):1839-43. PubMed ID: 25773834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
    Wei X; Chen D; Lv T; Li G; Qu S
    Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
    Tong YQ; Liu B; Zheng HY; Gu J; Liu H; Li F; Tan BH; Hartman M; Song C; Li Y
    Oncotarget; 2015 Sep; 6(28):25024-33. PubMed ID: 26317904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
    Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
    Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
    Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
    J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.